Researchers present new findings on the role of the protein Tau in certain brain diseases. Their report, which is based on laboratory studies, suggests that the drug “Rolofylline” could possibly alleviate learning and memory problems associated with aggregating Tau proteins.
Originally published at https://www.sciencedaily.com/releases/2016/10/161007084622.htm
No comments:
Post a Comment